Clinical Research in Cardiology

, Volume 100, Issue 6, pp 547–551 | Cite as

Sudden cardiac death in a patient with lamin A/C mutation in the absence of dilated cardiomyopathy or conduction disease

  • Philipp Ehlermann
  • Stephanie Lehrke
  • Theano Papavassiliu
  • Benjamin Meder
  • Martin Borggrefe
  • Hugo A. Katus
  • Rainer Schimpf
Letter to the Editors

References

  1. 1.
    Antoniades L, Eftychiou C, Kyriakides T, Christodoulou K, Katritsis DG (2007) Malignant mutation in the lamin A/C gene causing progressive conduction system disease and early sudden death in a family with mild form of limb-girdle muscular dystrophy. J Interv Card Electrophysiol 19:1–7PubMedCrossRefGoogle Scholar
  2. 2.
    Ashrafian H, Watkins H (2007) Reviews of translational medicine and genomics in cardiovascular disease: new disease taxonomy and therapeutic implications cardiomyopathies: therapeutics based on molecular phenotype. J Am Coll Cardiol 49:1251–1264PubMedCrossRefGoogle Scholar
  3. 3.
    Beckmann BM, Holinski-Feder E, Walter MC, Haseruck N, Reithmann C, Hinterseer M, Wilde AA, Kääb S Laminopathy presenting as familial atrial fibrillation. Int J Cardiol 145:394–396Google Scholar
  4. 4.
    Burkett EL, Hershberger RE (2005) Clinical and genetic issues in familial dilated cardiomyopathy. J Am Coll Cardiol 45:969–981PubMedCrossRefGoogle Scholar
  5. 5.
    Capell BC, Collins FS (2006) Human laminopathies: nuclei gone genetically awry. Nat Rev Genet 7:940–952PubMedCrossRefGoogle Scholar
  6. 6.
    Fatkin D, MacRae C, Sasaki T, Wolff MR, Porcu M, Frenneaux M, Atherton J, Vidaillet HJ Jr, Spudich S, De Girolami U, Seidman JG, Seidman C, Muntoni F, Muehle G, Johnson W, McDonough B (1999) Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med 341:1715–1724PubMedCrossRefGoogle Scholar
  7. 7.
    Graber HL, Unverferth DV, Baker PB, Ryan JM, Baba N, Wooley CF (1986) Evolution of a hereditary cardiac conduction and muscle disorder: a study involving a family with six generations affected. Circulation 74:21–35PubMedGoogle Scholar
  8. 8.
    Grunig E, Tasman JA, Kucherer H, Franz W, Kubler W, Katus HA (1998) Frequency and phenotypes of familial dilated cardiomyopathy. J Am Coll Cardiol 31:186–194PubMedCrossRefGoogle Scholar
  9. 9.
    Gupta P, Bilinska ZT, Sylvius N, Boudreau E, Veinot JP, Labib S, Bolongo PM, Hamza A, Jackson T, Ploski R, Walski M, Grzybowski J, Walczak E, Religa G, Fidzianska A, Tesson F (2010) Genetic and ultrastructural studies in dilated cardiomyopathy patients: a large deletion in the lamin A/C gene is associated with cardiomyocyte nuclear envelope disruption. Basic Res Cardiol 105:365–377PubMedCrossRefGoogle Scholar
  10. 10.
    Kass S, MacRae C, Graber HL, Sparks EA, McNamara D, Boudoulas H, Basson CT, Baker PB 3rd, Cody RJ, Fishman MC et al (1994) A gene defect that causes conduction system disease and dilated cardiomyopathy maps to chromosome 1p1–1q1. Nat Genet 7:546–551PubMedCrossRefGoogle Scholar
  11. 11.
    MacLeod HM, Culley MR, Huber JM, McNally EM (2003) Lamin A/C truncation in dilated cardiomyopathy with conduction disease. BMC Med Genet 4:4PubMedCrossRefGoogle Scholar
  12. 12.
    Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ (2005) Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 26:1461–1474PubMedCrossRefGoogle Scholar
  13. 13.
    McCrohon JA, Moon JC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJ, Pennell DJ (2003) Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 108:54–59PubMedCrossRefGoogle Scholar
  14. 14.
    Mestroni L, Rocco C, Gregori D, Sinagra G, Di Lenarda A, Miocic S, Vatta M, Pinamonti B, Muntoni F, Caforio AL, McKenna WJ, Falaschi A, Giacca M, Camerini (1999) Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. Heart Muscle Disease Study Group. J Am Coll Cardiol 34:181–190PubMedCrossRefGoogle Scholar
  15. 15.
    Meune C, Van Berlo JH, Anselme F, Bonne G, Pinto YM, Duboc D (2006) Primary prevention of sudden death in patients with lamin A/C gene mutations. N Engl J Med 354:209–210PubMedCrossRefGoogle Scholar
  16. 16.
    Michels VV, Moll PP, Miller FA, Tajik AJ, Chu JS, Driscoll DJ, Burnett JC, Rodeheffer RJ, Chesebro JH, Tazelaar HD (1992) The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med 326:77–82PubMedCrossRefGoogle Scholar
  17. 17.
    Moller P, Lunde P, Hovig T, Nitter-Hauge S (1979) Familial cardiomyopathy. Autosomally, dominantly inherited congestive cardiomyopathy with two cases of septal hypertrophy in one family. Clin Genet 16:233–243PubMedCrossRefGoogle Scholar
  18. 18.
    Nelson SD, Sparks EA, Graber HL, Boudoulas H, Mehdirad AA, Baker P, Wooley C (1998) Clinical characteristics of sudden death victims in heritable (chromosome 1p1–1q1) conduction and myocardial disease. J Am Coll Cardiol 32:1717–1723PubMedCrossRefGoogle Scholar
  19. 19.
    Pasotti M, Klersy C, Pilotto A, Marziliano N, Rapezzi C, Serio A, Mannarino S, Gambarin F, Favalli V, Grasso M, Agozzino M, Campana C, Gavazzi A, Febo O, Marini M, Landolina M, Mortara A, Piccolo G, Vigano M, Tavazzi L, Arbustini E (2008) Long-term outcome and risk stratification in dilated cardiolaminopathies. J Am Coll Cardiol 52:1250–1260PubMedCrossRefGoogle Scholar
  20. 20.
    Perrot A, Hussein S, Ruppert V, Schmidt HH, Wehnert MS, Duong NT, Posch MG, Panek A, Dietz R, Kindermann I, Bohm M, Michalewska-Wludarczyk A, Richter A, Maisch B, Pankuweit S, Ozcelik C (2009) Identification of mutational hot spots in LMNA encoding lamin A/C in patients with familial dilated cardiomyopathy. Basic Res Cardiol 104:90–99PubMedCrossRefGoogle Scholar
  21. 21.
    Raman SV, Sparks EA, Baker PM, McCarthy B, Wooley CF (2007) Mid-myocardial fibrosis by cardiac magnetic resonance in patients with lamin A/C cardiomyopathy: possible substrate for diastolic dysfunction. J Cardiovasc Magn Reson 9:907–913PubMedCrossRefGoogle Scholar
  22. 22.
    Silva MC, Meira ZM, Gurgel Giannetti J, da Silva MM, Campos AF, Barbosa Mde M, Starling Filho GM, Ferreira Rde A, Zatz M, Rochitte CE (2007) Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy. J Am Coll Cardiol 49:1874–1879PubMedCrossRefGoogle Scholar
  23. 23.
    Sylvius N, Bilinska ZT, Veinot JP, Fidzianska A, Bolongo PM, Poon S, McKeown P, Davies RA, Chan KL, Tang AS, Dyack S, Grzybowski J, Ruzyllo W, McBride H, Tesson F (2005) In vivo and in vitro examination of the functional significances of novel lamin gene mutations in heart failure patients. J Med Genet 42:639–647PubMedCrossRefGoogle Scholar
  24. 24.
    Sylvius N, Tesson F (2006) Lamin A/C and cardiac diseases. Curr Opin Cardiol 21:159–165PubMedCrossRefGoogle Scholar
  25. 25.
    Taylor MR, Fain PR, Sinagra G, Robinson ML, Robertson AD, Carniel E, Di Lenarda A, Bohlmeyer TJ, Ferguson DA, Brodsky GL, Boucek MM, Lascor J, Moss AC, Li WL, Stetler GL, Muntoni F, Bristow MR, Mestroni L (2003) Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. J Am Coll Cardiol 41:771–780PubMedCrossRefGoogle Scholar
  26. 26.
    van Berlo JH, de Voogt WG, van der Kooi AJ, van Tintelen JP, Bonne G, Yaou RB, Duboc D, Rossenbacker T, Heidbuchel H, de Visser M, Crijns HJ, Pinto YM (2005) Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death? J Mol Med 83:79–83PubMedCrossRefGoogle Scholar
  27. 27.
    Varghese A, Pennell DJ (2004) Late gadolinium enhanced cardiovascular magnetic resonance in Becker muscular dystrophy. Heart 90:e59PubMedCrossRefGoogle Scholar
  28. 28.
    Verga L, Concardi M, Pilotto A, Bellini O, Pasotti M, Repetto A, Tavazzi L, Arbustini E (2003) Loss of lamin A/C expression revealed by immuno-electron microscopy in dilated cardiomyopathy with atrioventricular block caused by LMNA gene defects. Virchows Arch 443:664–671PubMedCrossRefGoogle Scholar
  29. 29.
    Wu KC, Weiss RG, Thiemann DR, Kitagawa K, Schmidt A, Dalal D, Lai S, Bluemke DA, Gerstenblith G, Marban E, Tomaselli GF, Lima JA (2008) Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol 51:2414–2421PubMedCrossRefGoogle Scholar
  30. 30.
    Yilmaz A, Gdynia HJ, Ludolph AC, Klingel K, Kandolf R, Sechtem U (2010) Cardiomyopathy in a duchenne muscular dystrophy carrier and her diseased son: similar pattern revealed by cardiovascular MRI. Circulation 121:e237–e239PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Philipp Ehlermann
    • 1
  • Stephanie Lehrke
    • 1
  • Theano Papavassiliu
    • 2
  • Benjamin Meder
    • 1
  • Martin Borggrefe
    • 2
  • Hugo A. Katus
    • 1
  • Rainer Schimpf
    • 2
  1. 1.Innere Medizin III-KardiologieUniversitätsklinikum HeidelbergHeidelbergGermany
  2. 2.I. Medizinische KlinikUniversitätsmedizin MannheimMannheimGermany

Personalised recommendations